SCHEMBL13064

SCHEMBL13064

CN(c1cn(-c2ccccc2)nc1C(=O)N1CCOCC1)S(=O)(=O)c1ccccc1Br

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.48
PIK3CD O00329 5/20 0.44
PIK3R2 O00459 5/20 0.44
PIK3CA P42336 5/20 0.44
PIK3CB P42338 5/20 0.44
PIK3CG P48736 5/20 0.44
PIK3R5 Q8WYR1 5/20 0.44
PIK3R3 Q92569 5/20 0.44
TSHR P16473 2/20 0.44
L3MBTL1 Q9Y468 2/20 0.44
GAA P10253 1/20 0.44
MEN1 O00255 1/20 0.43
MAPK1 P28482 1/20 0.43
KMT2A Q03164 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
CYP1A2 P05177 1/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
HSD17B10 Q99714 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11745 0.86 ALDH1A1 (0.44) ALDH1A1PIK3CDPIK3R2PIK3CAPIK3CB
SCHEMBL13213 0.78 ALDH1A1 (0.48) ALDH1A1PIK3CDPIK3R2PIK3CAPIK3CB
SCHEMBL7660 0.72 ALDH1A1 (0.60) ALDH1A1PIK3CDPIK3R2PIK3CAPIK3CB
SCHEMBL13079 0.69 ALDH1A1 (0.56) ALDH1A1PIK3CDPIK3R2PIK3CAPIK3CB
SCHEMBL1927046 0.68 KMT2A (0.44) ALDH1A1GAAMEN1KMT2ASMN1; SMN2
SCHEMBL14133081 0.64 ALDH1A1 (1.00) ALDH1A1TSHRL3MBTL1GAAMEN1
SCHEMBL15918086 0.63 PIK3CD (0.46) ALDH1A1PIK3CDPIK3R2PIK3CAPIK3CB
SCHEMBL1053915 0.63 ALDH1A1 (0.44) ALDH1A1GAAMEN1MAPK1KMT2A
SCHEMBL15915212 0.62 RAB9A (0.52) ALDH1A1L3MBTL1GAAMEN1KMT2A
SCHEMBL1663182 0.62 ALDH1A1 (0.67) ALDH1A1TSHRL3MBTL1GAAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2499146-B1 TRICYCLIC PYRAZOL AMINE DERIVATIVES MERCK SERONO SA (CH) 2016-09-21 EP disclosed
EP-2499146-B1 TRICYCLIC PYRAZOL AMINE DERIVATIVES MERCK SERONO SA (CH) 2016-09-21 EP disclosed
US-9073940-B2 Tricyclic pyrazol amine derivatives MERCK SERONO SA (CH) 2015-07-07 US disclosed
US-9073940-B2 Tricyclic pyrazol amine derivatives MERCK SERONO SA (CH) 2015-07-07 US disclosed
US-9073940-B2 Tricyclic pyrazol amine derivatives MERCK SERONO SA (CH) 2015-07-07 US disclosed
US-20120238545-A1 TRICYCLIC PYRAZOL AMINE DERIVATIVES MERCK SERONO SA (CH) 2012-09-20 US disclosed
US-20120238545-A1 TRICYCLIC PYRAZOL AMINE DERIVATIVES MERCK SERONO SA (CH) 2012-09-20 US disclosed
US-20120238545-A1 TRICYCLIC PYRAZOL AMINE DERIVATIVES MERCK SERONO SA (CH) 2012-09-20 US disclosed
WO-2011058149-A1 TRICYCLIC PYRAZOL AMINE DERIVATIVES MERCK SERONO S.A. (CH) 2011-05-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120238545-A1 TRICYCLIC PYRAZOL AMINE DERIVATIVES PI4KB, MTOR, PI4KA ALDH1A1 3185/4885PIK3CD 5/4885PIK3R2 27/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.